Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$728M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$645M |
| 3 |
SPDR Gold Trust
GLD
|
+$413M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$401M |
| 5 |
SpaceX
SPCX
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.91B |
| 2 |
Micron Technology
MU
|
+$1.85B |
| 3 |
NVIDIA
NVDA
|
+$1.69B |
| 4 |
GE Vernova
GEV
|
+$809M |
| 5 |
Advanced Micro Devices
AMD
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.44% |
| 2 | Technology | 22.37% |
| 3 | Financials | 6.09% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Healthcare | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2126
Snap
SNAP
$10B
| $4.71M | ﹤0.01% |
873,016
-331,884
| -28% | -$1.72M |
2017 Q1
38 quarters
|
|
2127
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.61B
| $4.71M | ﹤0.01% |
119,968
-5,300
| -4% | -$215K |
2017 Q2
37 quarters
|
|
2128
National Energy Services Reunited Corp
NESR
$2.17B
| $4.66M | ﹤0.01% |
183,061
-93,277
| -34% | -$2.9M |
2024 Q4
7 quarters
|
|
2129
Ardelyx
ARDX
$849M
| $4.66M | ﹤0.01% |
1,363,236
+1,052,215
| +338% | +$4.51M |
2014 Q3
48 quarters
|
|
2130
NioCorp Developments
NB
$433M
| $4.65M | ﹤0.01% |
1,291,722
-743,254
| -37% | -$3.2M |
2025 Q2
5 quarters
|
|
2131
Liberty Live Group Series C
LLYVK
$10.2B
| $4.64M | ﹤0.01% |
47,761
+38,669
| +425% | +$3.96M |
2023 Q3
12 quarters
|
|
2132
UMB Financial
UMBF
$10.5B
| $4.64M | ﹤0.01% |
35,686
-31,248
| -47% | -$4.46M |
2013 Q2
53 quarters
|
|
2133
Broadstone Net Lease
BNL
$3.46B
| $4.63M | ﹤0.01% |
250,316
-11,736
| -4% | -$246K |
2020 Q4
23 quarters
|
|
2134
BlackRock ETF Trust iShares Defense Industrials and Tech Active ETF
IDEF
$4.03B
| $4.62M | ﹤0.01% |
147,921
+61,405
| +71% | +$2.01M |
2026 Q1
2 quarters
|
|
2135
CRISPR Therapeutics
CRSP
$5.01B
| $4.62M | ﹤0.01% |
83,477
-30,839
| -27% | -$1.66M |
2017 Q3
36 quarters
|
|
2136
Dimensional Short-Duration Fixed Income ETF
DFSD
$7.4B
| $4.62M | ﹤0.01% |
99,315
-12,613
| -11% | -$596K |
2024 Q3
8 quarters
|
|
2137
Vipshop
VIPS
$6.55B
| $4.61M | ﹤0.01% |
368,817
-30,134
| -8% | -$416K |
2013 Q4
51 quarters
|
|
2138
Energy Vault
NRGV
$578M
| $4.61M | ﹤0.01% |
1,161,647
+207,310
| +22% | +$761K |
2022 Q2
17 quarters
|
|
2139
Westlake Chemical Partners
WLKP
$762M
| $4.61M | ﹤0.01% |
217,489
-616
| -0.3% | -$13.4K |
2021 Q1
22 quarters
|
|
2140
NuScale Power
SMR
$2.11B
| $4.61M | ﹤0.01% |
583,095
-664,959
| -53% | -$5.98M |
2022 Q2
17 quarters
|
|
2141
Crane NXT
CXT
$3.55B
| $4.6M | ﹤0.01% |
97,668
-28,599
| -23% | -$1.44M |
2013 Q2
53 quarters
|
|
2142
Lionsgate Studios
LION
$3.78B
| $4.6M | ﹤0.01% |
410,585
-236,264
| -37% | -$2.91M |
2024 Q3
8 quarters
|
|
2143
Cognex
CGNX
$8.93B
| $4.6M | ﹤0.01% |
75,803
-45,690
| -38% | -$2.87M |
2013 Q2
53 quarters
|
|
2144
iShares Short Maturity Bond ETF
NEAR
$5.21B
| $4.6M | ﹤0.01% |
92,192
-202
| -0.2% | -$10.2K |
2017 Q3
36 quarters
|
|
2145
Abeona Therapeutics
ABEO
$241M
| $4.59M | ﹤0.01% |
874,649
+326,349
| +60% | +$2.03M |
2023 Q2
13 quarters
|
|
2146
Atlantic Union Bankshares
AUB
$5.64B
| $4.59M | ﹤0.01% |
120,940
-45,448
| -27% | -$1.87M |
2013 Q2
53 quarters
|
|
2147
UFP Industries
UFPI
$4.76B
| $4.58M | ﹤0.01% |
59,272
-21,789
| -27% | -$1.87M |
2013 Q2
53 quarters
|
|
2148
CALL
AstraZeneca
AZN
$293B
| $4.57M | ﹤0.01% |
28,000
-47,600
| -63% | -$7.93M |
2026 Q2
1 quarter
|
|
2149
Cabot Corp
CBT
$3.88B
| $4.55M | ﹤0.01% |
59,139
-29,765
| -33% | -$2.51M |
2013 Q2
53 quarters
|
|
2150
CALL
Zoom
ZM
$26.8B
| $4.54M | ﹤0.01% |
50,000
| – | – |
2025 Q2
5 quarters
|
|
Similar funds
Citigroup's Q3 2026 Portfolio in Review
As of Q3 2026, Citigroup held 6,419 positions worth $308B, up 1.8% from $303B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2026 filing shows 741 new, 2,043 increased, 2,737 reduced and 437 closed positions. Its largest new stake was SK Hynix Inc: 1,085,406 shares worth $200M. The largest sale was Microsoft, an estimated $1.91B.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- Citigroup's largest Q3 2026 buy was SK Hynix Inc: 1,085,406 shares worth $200M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $728M increase.
- Citigroup's biggest Q3 2026 reduction was Microsoft, cutting an estimated $1.91B.
- Citigroup fully exited Webster Financial in Q3 2026, selling an estimated $273M.
- Citigroup's ten largest holdings make up 21% of its $308B portfolio in Q3 2026.
- Citigroup opened 741 new positions and closed 437 in Q3 2026.
- Citigroup's portfolio value rose 1.8% quarter-over-quarter to $308B.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.